Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.16 (
calcineurin
)
17,112
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cysteine sulfinic acid decarboxylase
(
CSAD
), the rate-limiting enzyme in taurine biosynthesis, was found to be activated under conditions that favor protein phosphorylation and inactivated under conditions favoring protein dephosphorylation. Direct incorporation of 32P into purified
CSAD
has been demonstrated with [gamma 32P]ATP and PKC, but not PKA. In addition, the 32P labeling of
CSAD
was inhibited by PKC inhibitors suggesting that PKC is responsible for phosphorylation of
CSAD
in the brain. Okadaic acid had no effect on
CSAD
activity at 10 microM suggesting that
protein phosphatase-2C
(PrP-2C) might be involved in the dephosphorylation of
CSAD
. Furthermore, it was found that either glutamate- or high K(+)-induced depolarization increased
CSAD
activity as well as 32P-incorporation into
CSAD
in neuronal cultures, supporting the notion that the
CSAD
activity is endogenously regulated by protein phosphorylation in the brain. A model to link neuronal excitation, phosphorylation of
CSAD
and increase in taurine biosynthesis is proposed.
...
PMID:Regulation of taurine biosynthesis and its physiological significance in the brain. 963 49